年入25亿!香港最大药品零售商,龙丰集团冲刺IPO
Sou Hu Cai Jing·2025-11-30 18:16

Core Viewpoint - Long Fung Group Holdings Limited has submitted its main board listing application to the Hong Kong Stock Exchange, aiming to leverage its market position as the largest pharmaceutical retailer in Hong Kong by 2024 with a market share of 5.2% [1] Business Layout - Long Fung Group operates a network of 29 retail stores across Hong Kong, strategically located with 5 on Hong Kong Island, 10 in Kowloon, and 14 in the New Territories, primarily in street shop formats [3] - The flagship store in Mong Kok, with a total area of approximately 17,500 square feet, is projected to be the largest drugstore in Hong Kong by 2024, while the average store size is 4,254 square feet [3] - The company utilizes multiple online channels, including its official website and platforms like Tmall and JD.com, creating an omnichannel retail matrix [3] - The product range includes 11 categories such as traditional Chinese medicine, Western medicine, health supplements, and beauty products, with over 46,000 SKUs sold during the reporting period [3] Financial Performance - Revenue is projected to grow from HKD 1.094 billion in the 2023 fiscal year to HKD 2.461 billion in the 2025 fiscal year, reflecting a compound annual growth rate (CAGR) of 50% [4] - Gross margin is expected to increase from 24.9% to 31.6% over the same period [4] - The company recorded a loss of HKD 27.1 million in the 2023 fiscal year but is forecasted to achieve a net profit of HKD 145 million in 2024 and further increase to HKD 170 million in 2025 [4] - In the first quarter of the 2026 fiscal year, revenue reached HKD 697 million, a year-on-year increase of 42.5%, with net profit soaring by 130.7% to HKD 47.8 million [4] Use of IPO Proceeds - The IPO proceeds are intended for various purposes, including opening up to 11 new stores in Hong Kong by 2029, inventory procurement, employee training, and enhancing brand marketing through celebrity endorsements [5] - Additional plans include upgrading procurement offices in Japan and South Korea, improving IT systems, repaying loans, and seeking strategic investment opportunities [5]